COR vs. MCK, CAH, HSIC, PDCO, OMI, DHR, CVS, ELV, NTRA, and LH
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Elevance Health (ELV), Natera (NTRA), and Labcorp (LH). These companies are all part of the "medical" sector.
Cencora vs. Its Competitors
McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.
McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. McKesson pays out 11.0% of its earnings in the form of a dividend. Cencora pays out 25.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years.
McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
McKesson presently has a consensus target price of $696.42, suggesting a potential downside of 4.93%. Cencora has a consensus target price of $306.33, suggesting a potential upside of 2.29%. Given Cencora's higher probable upside, analysts clearly believe Cencora is more favorable than McKesson.
85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 10.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
McKesson has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.
In the previous week, McKesson had 7 more articles in the media than Cencora. MarketBeat recorded 41 mentions for McKesson and 34 mentions for Cencora. Cencora's average media sentiment score of 1.49 beat McKesson's score of 1.32 indicating that Cencora is being referred to more favorably in the news media.
McKesson has a net margin of 0.92% compared to Cencora's net margin of 0.55%. Cencora's return on equity of 344.71% beat McKesson's return on equity.
Summary
McKesson beats Cencora on 12 of the 20 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:COR) was last updated on 6/30/2025 by MarketBeat.com Staff